Transparency Market Research
Hypopigmentation causes patches of skin that are lighter than the overall skin tone. It may be localized or occur all over the body. In localized type of hypopigmentation, there may be several areas or patches on the skin that appear white. The size and shape of the white patches can vary widely. In people with hypopigmentation, there is either a decrease in melanin or melanocytes. A fall in the level of the amino acid tyrosine can also lead to hypopigmentation. Tyrosine is essential for the conversion of melanocytes to melanin. Hypopigmentation can occur in people of all races, but white patches may be more noticeable in people with darker skin. The absence of normal amounts of melanin caused by disease, burns, injury, or other trauma may lead to hypopigmentation.
The global hypopigmentation disorder treatment market is expected to expand substantially, due to a rise in the adoption of lasers for the treatment of pigmentation disorders, , decline in social taboos regarding pigmentation, rise in acceptance of pigmentation disorders treatment, and growing awareness about skin rejuvenation. In addition, improvements in lifestyle and an increase in disposable income are further likely to augment the market during the forecasted period. Rise in the prevalence of hypopigmentation disorders across the globe is likely to lead to an increase in the number of people undergoing treatment using drugs, lasers, microdermabrasion, and light therapy. This, in turn, is expected to boost demand for pigmentation disorder drugs and procedures, thereby driving the expansion of the hypopigmentation disorder treatment market. However, unfavorable reimbursement policies, competitive pricing, high equipment costs, and fear of risks associated with laser procedures are anticipated to hamper the market in the coming years.
The global hypopigmentation disorder treatment market can be segmented based on treatment, disease indication, end-user, and geography. Based on treatment, the global hypopigmentation disorder treatment market can be divided into topical drugs, laser therapy, chemical peels, phototherapy, and microdermabrasion. The topical drugs segment dominates the hypopigmentation disorder treatment market, due to a rise in the number of patients suffering from hypopigmentation disorders visiting skin specialists and the prescription of topical drugs to these patients. In terms of disease indication, the market can be classified into vitiligo, albinism, and others. Based on end-user, the market can be categorized into hospitals, aesthetic clinics, and dermatology centers.
In terms of geography, the hypopigmentation disorder treatment market can be segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. Each region is sub-segmented into countries such as the U.S., Canada, the U.K., Germany, Brazil, China, India, and GCC countries. The hypopigmentation disorders treatment market is dominated by Asia Pacific. The market in the region is likely gain market share and expand at a rapid pace during the forecast period. The market in Asia Pacific is likely to be boosted by an increase in the population, awareness about pigmentation disorder treatments and products, and expansion in economies of countries in the region. Furthermore, the hypopigmentation disorder treatment market in emerging economies of the Middle East, Latin America, and Africa is anticipated to expand in the coming years.
Key players operating in the hypopigmentation disorder treatment market are Bayer AG, Galderma S.A., Allergan, SkinCeuticals, EpiPharm AG, Pierre Fabre, Obagi Cosmeceuticals LLC, RXi Pharmaceuticals Corporation, Vivier Pharma, and other prominent players. In order to gain competitive advantage in the industry, major players are actively involved in various growth strategies. Collaborations, agreements, partnerships, and new product launches are some of the important strategies adopted by market players.
MRR.BIZ has been compiled in-depth market research data in the report after exhaustive primary and secondary research. Our team of able, experienced in-house analysts has collated the information through personal interviews and study of industry databases, journals, and reputable paid sources.
The report provides the following information:
The main aim of the report is to:
MRR.BIZ is a leading provider of strategic market research. Our vast repository consists research reports, data books, company profiles, and regional market data sheets. We regularly update the data and analysis of a wide-ranging products and services around the world. As readers, you will have access to the latest information on almost 300 industries and their sub-segments. Both large Fortune 500 companies and SMEs have found those useful. This is because we customize our offerings keeping in mind the specific requirements of our clients.